T0	Outcomes 21 30	bone loss
T1	Outcomes 264 277	osteoporosis.
T2	Outcomes 343 352	bone loss
T3	Outcomes 626 634	efficacy
T4	Outcomes 1269 1291	Lumbar and femoral BMD
T5	Outcomes 1364 1424	deoxypyridinoline (DPD) and bone alkaline phosphatase (BALP)
T6	Outcomes 1617 1633	marked bone loss
T7	Outcomes 1640 1672	increased levels of DPD and BALP
T8	Outcomes 1833 1881	lumbar and total hip BMD decreased significantly
T9	Outcomes 1970 1990	change significantly
T10	Outcomes 2068 2089	relevant side effects
T11	Outcomes 2186 2195	bone loss